{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:59:39Z","timestamp":1790204379567,"version":"4.1.0"},"reference-count":0,"publisher":"Pasifika Medical Association Group","issue":"1642","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NZMJ"],"abstract":"<jats:p>background: Lung cancer is immensely complex and resource-intensive to treat. Much of this burden falls to our public healthcare\nsystem; however, we currently do not know how much treatment we are providing for our most deadly cancer. Here we describe\nvolumes of publicly funded surgery, radiation and systemic therapy delivered to New Zealanders with lung cancer.\nmethods: We identified all lung cancers registered on the New Zealand Cancer Registry from 1 January 2015 to 31 December 2021\n(n=16,850). We linked cases to national treatment data, including inpatient, outpatient and pharmaceutical datasets. We counted the\nvolume of treatment received over a 2-year window from diagnosis and determined treatment per year of diagnosed cases. We also\ndetermined the average treatment received per diagnosed case, and per treated case.\nresults: For each year of new lung cancer diagnoses, our public system delivered 978 surgical-days of lung cancer\u2013specific surgery,\n11,027 attendance-days of radiation therapy and 9,108 dispensings of systemic therapy over the 2-year window following diagnosis.\nEach treated person received an average of 1.5 surgical-days of cancer-specific surgery, 11.5 attendance-days of radiation therapy and\n11.8 dispensings of systemic therapy, mostly intravenous chemotherapy. There were no obvious differences in average treatment by\nethnicity.\nconclusions: With the number of lung cancer diagnoses projected to increase over time, the volume of treatment delivered by our\nsystem will need to increase beyond the levels reported here. Among other actions, New Zealand must return to our world-leading\ntobacco cessation pathway to curb the significant future pressure caused by this common, complex and lethal cancer.<\/jats:p>","DOI":"10.26635\/6965.7383","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:08:12Z","timestamp":1790201292000},"page":"90-120","source":"Crossref","is-referenced-by-count":0,"title":["The volume of publicly funded treatment delivered to lung cancer cases in Aotearoa New Zealand"],"prefix":"10.26635","volume":"139","author":[{"given":"Jason","family":"Gurney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laird","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Koea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Signal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11177","published-online":{"date-parts":[[2026,9,25]]},"container-title":["New Zealand Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:08:15Z","timestamp":1790201295000},"score":1,"resource":{"primary":{"URL":"https:\/\/nzmj.org.nz\/journal\/vol-139-no-1642\/the-volume-of-publicly-funded-treatment-delivered-to-lung-cancer-cases-in-aotearoa-new-zealand"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":0,"journal-issue":{"issue":"1642","published-online":{"date-parts":[[2026,9,25]]}},"URL":"https:\/\/doi.org\/10.26635\/6965.7383","relation":{},"ISSN":["1175-8716"],"issn-type":[{"value":"1175-8716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}